Search
Search Results
##search.searchResults.foundPlural##
-
-
FASTING PLASMA GLUCOSE LEVELS WITHIN THE HIGH NORMAL RANGE ARE ASSOCIATED WITH A SIGNIFICANTLY INCREASED RISK OF FUTURE DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β THALASSEMIA: A DECADE-LONG MULTICENTER RETROSPECTIVE ANALYSIS Higher normal fasting plasma glucose and glucose dysregulation in β- thalassemia
581PDF: 210Html: 26 -
THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.
2069PDF: 1230Html: 267 -
A SEROPREVALENCE OF HBV, HCV AND HIV-1 AND CORRELATION WITH MOLECULAR MARKERS AMONG MULTI-TRANSFUSED THALASSEMIA PATIENTS IN WESTERN INDIA Incidence of serology & molecular of HIV, HBV and HCV in thalassemia patients
1295PDF: 749HTML: 479 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
2739PDF: 980HTML: 350Preferred Reviewers: 196 -
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OF THE ELDERLY: REVIEW OF THE LITERATURE AND PERSPECTIVES. Hematopoietic stem cell transplatation in the elderly fo Acute Myeloid Leukemia
1530PDF: 491HTML: 151 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
2865PDF: 1566HTML: 222 -
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6231PDF: 2070HTML: 13989Untitled: 186figure: 169 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3478PDF: 1155HTML: 4985Incidence age-standardized rates for HL across the Mediterranean basin: 187 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1632PDF: 1140HTML: 235 -
DIAMOND BLACKFAN ANEMIA: A TERTIARY CARE CENTRE EXPERIENCE
1778PDF: 842HTML: 3586Diamond Blackfan Anemia: A Tertiary care centre experience: 240 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4403PDF: 1895HTML: 17716 -
CAN WE PREDICT INCIPIENT DIABETES MELLITUS IN PATIENTS WITH TRANSFUSION DEPENDENT β-THALASSEMIA (β-TDT) REFERRED WITH A HISTORY OF PREDIABETES? Risk factors for incipient diabetes in thalassemia
1016PDF: 1319HTML: 94 -
ELEVATED P-SELECTIN IN SEVERE COVID-19: CONSIDERATIONS FOR THERAPEUTIC OPTIONS P-Selectine and COVID-19
1831PDF: 675HTML: 225 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3154PDF: 754HTML: 2929Figure 1a and 1b: 139Figure 2: 146Figure 3: 167Figure 4: 148Figure 5: 152Tables 1-5: 144 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2027PDF: 1025HTML: 15642COVER LETTER: 174 -
Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.
1317PDF: 817HTML: 10026cover letter to the editor: 154tile page: 239 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3197PDF: 920HTML: 2933 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1806HTML: 1403PDF: 1056 -
CURRENT ISSUES AND OPTIONS FOR HORMONAL CONTRACEPTION IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH SICKLE CELL DISEASE: AN UPDATE FOR HEALTH CARE PROFESSIONALS Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease
2109PDF: 1396HTML: 687 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2457PDF: 828HTML: 8801Efremov 1: 209Efremov 2: 171 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
2793PDF: 1205HTML: 2681Figure 1: 156 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1581PDF: 782HTML: 843jdoe, table 2 infections CML .doc: 179jdoe, table 1 infections CML .doc: 166 -
EXERCISE STRESS ECHOCARDIOGRAPHY WITH TISSUE DOPPLER IMAGING (TDI) DETECTS EARLY SYSTOLIC DYSFUNCTION IN BETA-THALASSEMIA MAJOR PATIENTS WITHOUT CARDIAC IRON OVERLOAD
1287PDF: 787HTML: 7860Manuscript after revision: 229Barbero10328-36310-after revision: 219 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4043PDF: 1557HTML: 887







